NCT05629559 - 4D-310 in Adults With Fabry Disease and Cardiac Involvement | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 16, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2030

Conditions

Fabry Disease

Interventions

BIOLOGICAL

4D-310

Single IV administration of 4D-310

Trial Locations (4)

NOT_YET_RECRUITING

Westmead Hospital, Westmead

ACTIVE_NOT_RECRUITING

Royal Melbourne Hospital, Melbourne

ACTIVE_NOT_RECRUITING

Royal Perth Hospital, Perth

RECRUITING

Taipei Veterans General Hospital, Taipei